Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ispas

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature|November 4, 2021
Percolation transitions in compressed SiO<sub>2</sub> glassesA Hasmy, S Ispas, B Hehlen
Physiological Measurement|November 1, 1996
Some boundary problems in electrical impedance tomographyM Pidcock, S Ciulli, S Ispas
Physiological Measurement|August 1, 1995
Singularities of mixed boundary value problems in electrical impedance tomographyM Pidcock, S Ciulli, S Ispas
The Journal of Chemical Physics|August 1, 2016
Nanoindentation of the pristine and irradiated forms of a sodium borosilicate glass: Insights from molecular dynamics simulationsD A Kilymis, J-M Delaye, S Ispas
The Journal of Chemical Physics|September 7, 2015
Behavior of sodium borosilicate glasses under compression using molecular dynamicsD A Kilymis, J-M Delaye, S Ispas
The New Zealand Dental Journal|August 8, 2013
Teething signs and symptoms: persisting misconceptions among health professionals in New ZealandRares S Ispas, Erin K Mahoney, Robin A Whyman
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious PubertyJ C Carel, M Roger, S Ispas, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotideJ M Kuhn, S Arlot, H Lefebvre, et al.
Gynecologic Oncology|October 20, 1999
A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation studyC Lhommé, P Vennin, N Callet, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature|November 4, 2021
Percolation transitions in compressed SiO<sub>2</sub> glassesA Hasmy, S Ispas, B Hehlen
Physiological Measurement|November 1, 1996
Some boundary problems in electrical impedance tomographyM Pidcock, S Ciulli, S Ispas
Physiological Measurement|August 1, 1995
Singularities of mixed boundary value problems in electrical impedance tomographyM Pidcock, S Ciulli, S Ispas
The Journal of Chemical Physics|August 1, 2016
Nanoindentation of the pristine and irradiated forms of a sodium borosilicate glass: Insights from molecular dynamics simulationsD A Kilymis, J-M Delaye, S Ispas
The Journal of Chemical Physics|September 7, 2015
Behavior of sodium borosilicate glasses under compression using molecular dynamicsD A Kilymis, J-M Delaye, S Ispas
The New Zealand Dental Journal|August 8, 2013
Teething signs and symptoms: persisting misconceptions among health professionals in New ZealandRares S Ispas, Erin K Mahoney, Robin A Whyman
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious PubertyJ C Carel, M Roger, S Ispas, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotideJ M Kuhn, S Arlot, H Lefebvre, et al.
Gynecologic Oncology|October 20, 1999
A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation studyC Lhommé, P Vennin, N Callet, et al.
Pageof 1